Three senior officials at the National Institute of Allergy and Infectious Diseases have reportedly been told to either accept reassignment outside the agency or resign, according to sources familiar with the situation.

The reported shake-up comes as major leadership changes continue across the institute following the return of Donald Trump to office.

Reports indicate that eight of the top ten officials at NIAID have now either departed or been pushed out since the administration change earlier this year.

The institute, which played a central role during the COVID-19 pandemic, has remained under intense political scrutiny in recent years over its handling of public health guidance, vaccine policy, and infectious disease research.

The latest departures reportedly involve senior figures connected to infectious disease programs and research administration.

The leadership changes are also occurring as some scientists involved in COVID-era research and pandemic response efforts face legal and political investigations in the United States.

Critics argue that the moves could weaken America’s public health and infectious disease infrastructure during a period when global health agencies continue monitoring emerging virus threats.

Supporters of the administration, however, say the changes are part of broader government restructuring efforts and increased oversight of federal health agencies.

NIAID has historically been one of the most influential biomedical research institutions in the country, overseeing major research programs related to vaccines, immunology, infectious diseases, and pandemic preparedness.

The institute previously operated under the long-time leadership of Anthony Fauci, who became one of the most recognized public health figures during the COVID-19 pandemic.

Scientists and health experts have expressed concern that continued political pressure on federal health agencies may discourage research collaboration and affect future public trust in scientific institutions.

The reported reassignments also come at a time when federal agencies are reviewing budgets, restructuring departments, and reassessing pandemic-related policies implemented during previous administrations.

Neither the NIH nor NIAID has publicly released detailed comments regarding the reported personnel decisions.

The developments are likely to intensify ongoing debates surrounding pandemic accountability, scientific independence, and the future direction of U.S. public health leadership.